Karyopharm Therapeutics (KPTI) Other Working Capital Changes (2012 - 2025)
Karyopharm Therapeutics' (KPTI) quarterly Other Working Capital Changes came in at -$297000.0 in Q1 2021, up 71.82% YoY from -$172853.7 in Q1 2020, and up 90.67% on a QoQ basis from -$3.2 million in Q2 2020.
Karyopharm Therapeutics (KPTI) Other Working Capital Changes (2012 - 2025) Analysis & Trends
Karyopharm Therapeutics (KPTI) has 3 years of Other Working Capital Changes data on file, last reported at -$297000.0 in Q1 2021.
- Quarterly Other Working Capital Changes rose 71.82% year-over-year to -$297000.0 in Q1 2021, while the trailing twelve-month figure through Dec 2021 was -$297000.0 (up 92.99% YoY) and the FY2021 annual result came in at -$297000.0, up 92.99% from the prior year.
- Other Working Capital Changes advanced to -$297000.0 in Q1 2021, from -$3.2 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $26.2 million in Q4 2021 to a low of -$7.2 million in Q3 2021.
- A 5-year average of $1.4 million and a median of -$366000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 71.82% in 2021, down 71.82% in 2021.
- Tracing KPTI's Other Working Capital Changes over 3 years: stood at -$1000.0 in 2018, then plunged by 318100.0% to -$3.2 million in 2020, then soared by 90.67% to -$297000.0 in 2021.
- The last three Other Working Capital Changes figures came in at -$297000.0 (Q1 2021), -$3.2 million (Q2 2020), and -$1.1 million (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Karyopharm Therapeutics | 56.72 Mn | 56.72 Mn | 32.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.78 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | -4.70 Mn |
| Sep 30, 2025 | -4.70 Mn |
| Sep 30, 2025 | -4.70 Mn |
| Jun 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Mar 31, 2025 | 262,000.00 |
| Mar 31, 2025 | 262,000.00 |
| Mar 31, 2025 | 262,000.00 |
| Dec 31, 2024 | -1.88 Mn |
| Dec 31, 2024 | -1.88 Mn |
| Dec 31, 2024 | -1.88 Mn |
| Sep 30, 2024 | -167,000.00 |
| Sep 30, 2024 | -167,000.00 |
| Sep 30, 2024 | -167,000.00 |
| Jun 30, 2024 | -565,000.00 |
| Jun 30, 2024 | -565,000.00 |